XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Earnings Per Share [Abstract]        
Net loss attributable to Adaptive Biotechnologies Corporation $ (47,810) $ (52,046) $ (105,509) $ (114,782)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 144,397,693 142,363,589 143,956,867 142,032,261
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.33) $ (0.37) $ (0.73) $ (0.81)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 144,397,693 142,363,589 143,956,867 142,032,261
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.33) $ (0.37) $ (0.73) $ (0.81)